Crews Bank & Trust
BankPosition in ACRV — Acrivon Therapeutics, Inc.
CIK 2052279
PORT CHARLOTTE, FL
Position in ACRV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,858
New position
Shares Held
1,044
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crews Bank & Trust holds $920,984 across 7 Biotechnology names. ACRV ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
935 | $867,464 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
300 | $16,500 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
1,800 | $15,759 | |
| 4 | MNKD |
Mannkind Corp
|
2,648 | $11,280 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12 | $5,960 | |
| 6 | LEXX |
Lexaria Bioscience Corp.
|
3,864 | $2,163 | |
| 7 | ACRV |
Acrivon Therapeutics, Inc.
This page
|
1,044 | $1,858 |
All Filings in ACRV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,858 | 1,044 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||